Moneycontrol PRO
HomeNewsOpinionAdvent’s rush to scale up Suven Pharma leads it to another acquisition

Advent’s rush to scale up Suven Pharma leads it to another acquisition

The NJ Bio acquisition follows Sapala Organics purchase in June

December 13, 2024 / 07:55 IST
Acquisitions and management changes has stoked optimism about Suven Pharma’s growth
Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts